Works matching IS 1699048X AND DT 2020 AND VI 22 AND IP 4
Results: 19
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 457, doi. 10.1007/s12094-019-02167-y
- By:
- Publication type:
- Article
Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 555, doi. 10.1007/s12094-019-02161-4
- By:
- Publication type:
- Article
Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 447, doi. 10.1007/s12094-019-02165-0
- By:
- Publication type:
- Article
Breast cancer and cytomegalovirus.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 585, doi. 10.1007/s12094-019-02164-1
- By:
- Publication type:
- Article
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 576, doi. 10.1007/s12094-019-02163-2
- By:
- Publication type:
- Article
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 468, doi. 10.1007/s12094-019-02162-3
- By:
- Publication type:
- Article
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 603, doi. 10.1007/s12094-019-02166-z
- By:
- Publication type:
- Article
ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 563, doi. 10.1007/s12094-019-02160-5
- By:
- Publication type:
- Article
Bemiparin as a long-term treatment for venous thrombosis in cancer patients: the ELEBAMA study.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 616, doi. 10.1007/s12094-019-02159-y
- By:
- Publication type:
- Article
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 546, doi. 10.1007/s12094-019-02158-z
- By:
- Publication type:
- Article
Red and processed meat consumption and esophageal cancer risk: a systematic review and meta-analysis.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 532, doi. 10.1007/s12094-019-02157-0
- By:
- Publication type:
- Article
Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 522, doi. 10.1007/s12094-019-02156-1
- By:
- Publication type:
- Article
Resection of liver metastases from breast cancer: a multicentre analysis.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 512, doi. 10.1007/s12094-019-02155-2
- By:
- Publication type:
- Article
Outpatient management of incidental pulmonary embolism in cancer patient.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 612, doi. 10.1007/s12094-019-02153-4
- By:
- Publication type:
- Article
Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 503, doi. 10.1007/s12094-019-02152-5
- By:
- Publication type:
- Article
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 495, doi. 10.1007/s12094-019-02151-6
- By:
- Publication type:
- Article
The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 486, doi. 10.1007/s12094-019-02150-7
- By:
- Publication type:
- Article
Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 4, p. 474, doi. 10.1007/s12094-019-02149-0
- By:
- Publication type:
- Article